IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
A Multiple Ascending Dose Study of ETC-1002 in Subjects With Mild Dyslipidemia
This study has been completed.
Sponsor:
Esperion Therapeutics
Information provided by:
Esperion Therapeutics
ClinicalTrials.gov Identifier:
NCT01105598
First received: April 15, 2010
Last updated: November 16, 2010
Last verified: November 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | October 2010 |
| Primary Completion Date: | October 2010 (Final data collection date for primary outcome measure) |